Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase II Emphasis-261622006
Sloan-Kettering Institute for Cancer Research
Search grants from Sloan-Kettering Institute for Cancer Research
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma
Er Stress as Early Sensor of Nutrient Deprivation
Biogenesis Of The Salmonella-containing Vacuole
Function of Xenobiotic Receptors
High-resolution studies of visual attention in human superior colliculus
Recently added grants:
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer
Development of a multi-omic clinical decision platform to guide personalized therapy
Characterizing and targeting intra-tumor heterogeneity in triple negative breast cancer chemoresistance and multi-organ metastasis
Developing the evidence base for overdose policies: a multilevel analysis of NHBS
Molecular dissection of acute and chronic menthol interactions
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM622006-001
Application #
7339522
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
City
State
Country
Zip Code
Comments
Be the first to comment on this grant